Photobiomodulation reduces hippocampal apoptotic cell death and produces a Raman spectroscopic "signature"

Apoptotic cell death within the brain represents a significant contributing factor to impaired post-traumatic tissue function and poor clinical outcome after traumatic brain injury. After irradiation with light in the wavelength range of 600-1200 nm (photobiomodulation), previous investigations have...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 17; no. 3; p. e0264533
Main Authors Davies, David J, Hadis, Mohammed, Di Pietro, Valentina, Lazzarino, Giuseppe, Forcione, Mario, Harris, Georgia, Stevens, Andrew R, Soon, Wai Cheong, Goldberg Oppenheimer, Pola, Milward, Michael, Belli, Antonio, Palin, William M
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 03.03.2022
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Apoptotic cell death within the brain represents a significant contributing factor to impaired post-traumatic tissue function and poor clinical outcome after traumatic brain injury. After irradiation with light in the wavelength range of 600-1200 nm (photobiomodulation), previous investigations have reported a reduction in apoptosis in various tissues. This study investigates the effect of 660 nm photobiomodulation on organotypic slice cultured hippocampal tissue of rats, examining the effect on apoptotic cell loss. Tissue optical Raman spectroscopic changes were evaluated. A significantly higher proportion of apoptotic cells 62.8±12.2% vs 48.6±13.7% (P<0.0001) per region were observed in the control group compared with the photobiomodulation group. After photobiomodulation, Raman spectroscopic observations demonstrated 1440/1660 cm-1 spectral shift. Photobiomodulation has the potential for therapeutic utility, reducing cell loss to apoptosis in injured neurological tissue, as demonstrated in this in vitro model. A clear Raman spectroscopic signal was observed after apparent optimal irradiation, potentially integrable into therapeutic light delivery apparatus for real-time dose metering.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Competing Interests: The development of this novel concept has resulted in a patent pending application from our group relating to the invasive delivery of PBM, together with the use of temporarily implanted apparatus to establish an optimal dose feedback loop via an optical spectroscopic brain interface (UK Patent Application No 2006201.4). There are no other competing interests to declare, including those relating to employment, consultancy, other patents or products in development. The authors confirm that this does not alter our adherence to all PLOS ONE policies on sharing data and materials.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0264533